Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The Augmented Hematologist: Human-AI Feedback Loops to Assist Differential Cell Count during the Analysis of Bone Marrow Aspirates

David Bermejo-Peláez, Sandra Rueda Charro, Adriana Mousa, Elisa Alamo, Maria Garcia Roa, Roberto Trelles-Martínez, Marta Hidalgo Soto, Alejandro Bobes-Fernández, Roberto Garcia-Vicente, María Luz Morales, Alba Rodríguez García, Alejandra Ortiz-Ruiz, Alberto Blanco-Sánchez, Lin Lin, Elena Dacal, Rosa Ayala, Miguel Luengo-Oroz, María Linares, Joaquin Martinez Lopez

Blood (2022) 140 (Supplement 1): 10736–10737.

https://doi.org/10.1182/blood-2022-160005

Published: 2022

Journal Articles

Universally Observed Loss of BCL7A Allows Activation of IRF4 and Its Transcriptional Activity in Multiple Myeloma Cells

Chandraditya Chakraborty, Srikanth Talluri, Eugenio Morelli, Sanika Derebail, Yao Yao, Yan Xu, Alba Rodríguez García, María Linares, Kenneth C. Anderson, Moritz Binder, Mehmet K. Samur, Mariateresa Fulciniti, Nikhil C. Munshi

Blood (2021) 138 (Supplement 1): 2667.

https://doi.org/10.1182/blood-2021-153462

Published: 2021

Journal Articles

The Spliceosome As a New Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia

María Luz Morales, Roberto Garcia-Vicente, Alba Rodríguez García, Noemí Álvarez Sánchez-Redondo, Alejandra Ortiz-Ruiz, Armando Reyes-Palomares, Ricardo Sanchez, Vanesa Garrido-Garcia, Gonzalo Carreño-Tarragona, Sylvie Hermouet, Rosa Ayala, Joaquin Martinez Lopez, María Linares

Blood (2021) 138 (Supplement 1): 3334.

https://doi.org/10.1182/blood-2021-150879

Published: 2021

Journal Articles

Study of the Role of Splicing Factor SRRM2 in Cytarabine Treatment Resistance in Acute Myeloid Leukemia

María Luz Morales, Roberto Garcia-Vicente, Noemí Álvarez Sánchez-Redondo, Alba Rodríguez García, Alejandra Ortiz-Ruiz, Armando Reyes-Palomares, PhD, Sylvie Hermouet, MD PhD, Rosa Ayala, Joaquin Martinez-Lopez, MD PhD, María Linares

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-139338

Published: 2020

Journal Articles

Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches

Ricardo Sanchez, Juan Manuel de la Rosa, Yanira Heredia, Jaime Carrillo, Laura Rufian, Esther Onecha, PhD, Gonzalo Carreño Gomez-Tarragona, MD, Chongwu Wang, María Linares, Jose Sanchez-Pina, Inmaculada Rapado, PhD, Josep-Maria Ribera, Rosa Ayala, Joaquin Martinez-López, Santiago Barrio

Blood (2020) 136 (Supplement 1): 6–8.

https://doi.org/10.1182/blood-2020-139561

Published: 2020

Journal Articles

Disruption of the m-SWI/SNF Complex Mediated By Recurrent Non-Coding Mutations in BCL7A Induces Tumor Cell Proliferation in Multiple Myeloma

Chandraditya Chakraborty, PhD, Eugenio Morelli, MD, Srikanth Talluri, PhD, Sanika Derebail, MS, Yan Xu, MD, Yao Yao, María Linares, Alba Rodríguez García, Kenneth Anderson, MD, Mehmet Kemal Samur, PhD, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-142178

Published: 2020

Journal Articles

Recurrent Non-Coding Mutations in BCL7A May Have Significant Functional Consequence in Multiple Myeloma

Chandraditya Chakraborty, PhD, Eugenio Morelli, MD, María Linares, PhD, Kenneth C. Anderson, MD, Mehmet Kemal Samur, PhD, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 857.

https://doi.org/10.1182/blood-2019-129155

Published: 2019

Journal Articles

Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity

Alejandra Ortiz-Ruiz, BSc, Yanira Ruiz-Heredia, Mehmet Samur, PhD, Pedro Aguilar-Garrido, Maria Luz Morales, Antonio Valeri, PhD, Almudena Garcia-Ortiz, PhD, Santiago Barrio, PhD, Carmen Bárcena, Rosa Maria Garcia-Martin, Vanesa Garrido, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD, María Teresa Cedena, Joaquin Martinez-Lopez, MD PhD, Maria Linares, PhD, Miguel Gallardo, PhD

Blood (2019) 134 (Supplement_1): 4408.

https://doi.org/10.1182/blood-2019-123950

Published: 2019

Journal Articles

The Role of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies

Alba Rodríguez García, María Linares, PhD, Nicolas Mennesson, Alfredo Pérez-Revilla, Ricardo Sanchez, PhD MD, Alejandra Leivas, PhD BS, MSc, Rafael Alonso Fernández, MD, Edith Bigot-Corbel, PhD, Sylvie Hermouet, Joaquin Martinez-Lopez, MD PhD

Blood (2019) 134 (Supplement_1): 5560.

https://doi.org/10.1182/blood-2019-126549

Published: 2019

Journal Articles

Protein Carbonylation Pattern Is Altered in Myelodisplastic Syndromes

Alba Rodríguez García, Maria Linares, Maria Luz Morales, Vanesa Garrido, Irene Baquero, Maria Teresa Cedena Romero, MD PhD, Ricardo Sanchez, Rosa Ayala, MD PhD, Jose Manuel Bautista, Joaquin Martinez Lopez, MD

Blood (2018) 132 (Supplement 1): 5502.

https://doi.org/10.1182/blood-2018-99-112799

Published: 2018

Journal Articles

The Role of Hepatitis C Virus in the Development of Multiple Myeloma: A Case Study

Alba Rodríguez García, María Linares, PhD, Nicolas Mennesson, Beatriz Sanchez-Vega, PhD, Ricardo Sanchez, Rafael Alonso Fernandez, Edith Bigot-Corbel, PhD, Sylvie Hermouet, Joaquin Martinez Lopez, MD

Blood (2018) 132 (Supplement 1): 5592.

https://doi.org/10.1182/blood-2018-99-112842

Published: 2018

Journal Articles

Altered Carbonylation Pattern in Myelodisplastic Syndromes

María Linares, PhD, Alba Rodríguez-García, Keina Quiroz, Maria Teresa Cedena, Alicia Arenas, PhD, Maria Luz Morales, Laura Sánchez-Vega, Rosa Ayala, Jose Manuel Bautista, Joaquín Martínez

Blood (2017) 130 (Supplement 1): 5302.

https://doi.org/10.1182/blood.V130.Suppl_1.5302.5302

Published: 2017

Journal Articles

5q+ MDS Patients with Low RPS14 Expression Are Candidates to Immune-Modulating Drugs

María Linares, PhD, Inmaculada Rapado, Yanira Ruiz-Heredia, Maria Teresa Cedena, Keina Quiroz, Santiago Barrio, PhD, Rosa Ayala, Joaquín Martínez

Blood (2017) 130 (Supplement 1): 5303.

https://doi.org/10.1182/blood.V130.Suppl_1.5303.5303

Published: 2017

Journal Articles

Abnormalities in Mitochondrial DNA Copy Number Have Pathogenetic and Prognostic Implications in Multiple Myeloma

Blood (2017) 130 (Supplement 1): 4378.

https://doi.org/10.1182/blood.V130.Suppl_1.4378.4378

Published: 2017

Journal Articles

Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma

Blood (2017) 129 (16): 2233–2245.

https://doi.org/10.1182/blood-2016-06-724831

Published: 2017

Includes: Supplemental data

Journal Articles

Preclinical Evidence That Trametinib Enhances the Response to Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia

Joaquín Martínez-López, MD PhD, María Linares, Maria Luz Morales, Alicia Arenas, Ivana Zagorac, Rosa M. Ayala, MD PhD, Nerea Castro, Inmaculada Rapado, PhD, Miguel Quintela-Fandino

Blood (2016) 128 (22): 1581.

https://doi.org/10.1182/blood.V128.22.1581.1581

Published: 2016

Journal Articles

Nilotinib Plus Ruxolitinib Produces Anti-Fibrotic Effect

Alicia Arenas, Rosa M. Ayala, MD PhD, María Linares, PhD, Joaquín Martínez-López, MD PhD

Blood (2016) 128 (22): 5497.

https://doi.org/10.1182/blood.V128.22.5497.5497

Published: 2016

NARROW

The Augmented Hematologist: Human-AI Feedback Loops to Assist Differential Cell Count during the Analysis of Bone Marrow Aspirates

Universally Observed Loss of BCL7A Allows Activation of IRF4 and Its Transcriptional Activity in Multiple Myeloma Cells

The Spliceosome As a New Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia

Study of the Role of Splicing Factor SRRM2 in Cytarabine Treatment Resistance in Acute Myeloid Leukemia

Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches

Disruption of the m-SWI/SNF Complex Mediated By Recurrent Non-Coding Mutations in BCL7A Induces Tumor Cell Proliferation in Multiple Myeloma

Recurrent Non-Coding Mutations in BCL7A May Have Significant Functional Consequence in Multiple Myeloma

Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity

The Role of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies

Protein Carbonylation Pattern Is Altered in Myelodisplastic Syndromes

The Role of Hepatitis C Virus in the Development of Multiple Myeloma: A Case Study

Altered Carbonylation Pattern in Myelodisplastic Syndromes

5q+ MDS Patients with Low RPS14 Expression Are Candidates to Immune-Modulating Drugs

Abnormalities in Mitochondrial DNA Copy Number Have Pathogenetic and Prognostic Implications in Multiple Myeloma

Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma

Preclinical Evidence That Trametinib Enhances the Response to Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia

Nilotinib Plus Ruxolitinib Produces Anti-Fibrotic Effect

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only